TRYPTASE - ANVISA Registration 80254180154
Access comprehensive regulatory information for TRYPTASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180154 and manufactured by PHADIA AB. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including PHADIA AB, IMMUNDIAGNOSTIK AG, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80254180154
25351274865201313
04930429000139
Company Information
Dates and Status
Jul 01, 2013
VIGENTE
09/18/2025 19:00:01
TRYPTASE
ImmunoCAP Tryptase Conjugate 50
PHADIA AB
80254180153
Jul 01, 2013
IMMUNOGLOBULIN E
IMMUNOCAP SPECIFIC IGE ANTI-IGE
PHADIA AB
80254180020
Sep 19, 2005
EOSINOPHIL CATIONIC PROTEIN
ImmunoCAP ECP anti-ECP
PHADIA AB
80254180320
Sep 09, 2019
IMMUNOGLOBULIN E
IMMUNOCAP TOTAL IGE ANTI-IGE
PHADIA AB
80254180015
Sep 12, 2005
IMMUNOGLOBULIN E
ImmunoCAP Specific IgE Control H
PHADIA AB
80254180150
Jun 24, 2013
TRIPTASE
IDK® Tryptase ELISA
IMMUNDIAGNOSTIK AG
80464810824
May 02, 2023
TRIPTASE
ImmunoCAP Tryptase Curve Control Strip
PHADIA AB
80254180155
Jul 08, 2013
TRIPTASE
ImmunoCAP Tryptase Calibrator Strip
PHADIA AB
80254180156
Jul 08, 2013
TRIPTASE
ImmunoCAP Tryptase Conjugate 50
PHADIA AB
80254180153
Jul 01, 2013